Search results for: 'Cancer Diagnostics Market'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, digital solutions, immersive technologies, and diagnostics industry. The issue includes advanced medical devices such as hand-held robotic device for neurological interventions, non-surgical birth control ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) ) profiles a wide range of innovations from the advanced medical devices, digital health, and diagnostics industry. The issue includes advanced medical devices such as sub-cutaneous implant for lymphedema therapy, portable cooling device, high-definition blood vessels imaging ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, neuromodulation systems, and diagnostic solutions industry. The issue features advanced medical devices such as intelligent drug delivery system, immersive therapeuti...

Image-guided cancer ablation systems are minimally invasive medical technologies that use real-time imaging to accurately guide the placement of an ablation device into a tumor, enabling localized destruction of cancerous tissue while minimizing damage to surrounding healthy structures.The increasing global cancer burden is a key factor driving the...

This research services provides an overview of the global CAD in breast cancer screening market and a 5-year forecast from 2021 to 2026. The market will grow from $118.0 million in 2021 to $165.7 million in 2026, increasing at a compound annual growth rate (CAGR) of 7.0%. The mammo-CAD and ultrasound-CAD segments will grow at the highest rates due ...

This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, wearables, medical imaging and diagnostics industry. The issue includes advanced medical devices such as chip-sized laser spectrometer, needle-free automated drug delivery system, AR/VR-based digital neuro...

The study provides a U.S. market scenario for molecular diagnostics markets. The markets are divided as Infectious diseases, cancer, and pharmacogenomics markets. Emerging markets in molecular diagnostics are also discussed. Product analysis and technology analysis are detailed in the study. The study provides competitive position of key market par...